We are live on
!
Find out more
MWA
Marshall Wace Asia Portfolio holdings
AUM
$4.23B
1-Year Est. Return
69.9%
This Fund
S&P 500
This Quarter
Est. Return
+17.28%
1 Year Est. Return
+69.9%
3 Year Est. Return
+148.72%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.31B
AUM Growth
+$592M
(+22%)
Cap. Flow
+$244M
Cap. Flow
% of AUM
7.37%
Top 10 Holdings %
Top 10 Hldgs %
33.63%
Holding
133
New
43
Increased
29
Reduced
18
Closed
43
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SBNY
Signature Bank
SBNY
|
+$78.1M |
| 2 |
Pinduoduo
PDD
|
+$76.9M |
| 3 |
Nutanix
NTNX
|
+$72.8M |
| 4 |
Amazon
AMZN
|
+$68.9M |
| 5 |
KSU
Kansas City Southern
KSU
|
+$67.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$101M |
| 2 |
Bank of America
BAC
|
+$66.3M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$65.1M |
| 4 |
The Mosaic Company
MOS
|
+$59.3M |
| 5 |
Nutrien
NTR
|
+$57.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 20.37% |
| 2 | Financials | 20.28% |
| 3 | Technology | 15.03% |
| 4 | Industrials | 11.97% |
| 5 | Materials | 9.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Union Pacific
UNP
$174B
| – | – |
-247,355
| Closed | -$34.2M |
|
127
Victory Capital Holdings
VCTR
$6.19B
| – | – |
-3
| Closed | – |
|
128
VeriSign
VRSN
$26.2B
| – | – |
-13,350
| Closed | -$1.98M |
|
129
Weibo
WB
$2B
| – | – |
-3,206
| Closed | -$187K |
|
130
Weyerhaeuser
WY
$18B
| – | – |
-1,110,596
| Closed | -$24.3M |
|
|
SIOX
131
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| – | – |
-174
| Closed | -$1K |
|
|
ABMD
132
DELISTED
Abiomed Inc
ABMD
| – | – |
-47,537
| Closed | -$15.5M |
|
|
ETFC
133
DELISTED
E*Trade Financial Corporation
ETFC
| – | – |
-133,609
| Closed | -$5.86M |
|
Similar funds
HB
3SCA
HFCIV
DVC
PAM
NAM
AIC
XEA
Marshall Wace Asia's Q1 2019 Portfolio in Review
As of Q1 2019, Marshall Wace Asia held 133 positions worth $3.31B, up 22% from $2.72B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Marshall Wace Asia deployed $244M of net new capital in Q1 2019, opening 43 new positions and adding to 29 existing holdings. Its largest new stake was Signature Bank: 613,057 shares worth $78.5M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 20% of assets, up from 16% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Hilton Worldwide, an estimated $36.4M trimmed.
- Marshall Wace Asia's largest Q1 2019 buy was Signature Bank: 613,057 shares worth $78.5M.
- Marshall Wace Asia added most to Pinduoduo in Q1 2019, an estimated $76.9M increase.
- Marshall Wace Asia's biggest Q1 2019 reduction was Hilton Worldwide, cutting an estimated $36.4M.
- Marshall Wace Asia fully exited Boston Scientific in Q1 2019, selling an estimated $101M.
- Marshall Wace Asia's ten largest holdings make up 34% of its $3.31B portfolio in Q1 2019.
- Marshall Wace Asia opened 43 new positions and closed 43 in Q1 2019.
- Marshall Wace Asia's portfolio value rose 22% quarter-over-quarter to $3.31B.
Based on Marshall Wace Asia's 13F filing for Q1 2019, filed 14 May 2019.